Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

ucb biopharma ltda. - cepa influenza tipo a, cepa influenza tipo b, cepa influenza tipo a (h1n1), cepa influenza tipo a (h3n2) - vacinas

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

fundaÇÃo oswaldo cruz - poliovírus tipo 2, poliovírus tipo 1, poliovírus tipo 3 - vacinas

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

medstar importaÇÃo e exportaÇÃo eireli - cepa influenza tipo b, cepa influenza tipo a (h1n1), cepa influenza tipo a (h3n2) - vacinas

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi-aventis farmacÊutica ltda - poliovírus inativados tipo 1, poliovírus inativados tipo 2, poliovírus inativados tipo 3 - vacinas

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

instituto butantan - vacina contra raiva - vacinas

União Europeia - português - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - porcos - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

União Europeia - português - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunológicos para suidae - suínos (para engorda) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

União Europeia - português - EMA (European Medicines Agency)

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vacinas - active immunisation against h5 subtype of influenza a virus.

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

alcon laboratÓrios do brasil ltda. - glicocorticoides top. simp. exc. uso oftalm.

União Europeia - português - EMA (European Medicines Agency)

virbac s.a. - antigénio de envelope felv rp-45 purificado - inativadas vacinas virais - gatos - imunização ativa de gatos de oito semanas contra leucemia felina para prevenção de viremia persistente e sinais clínicos da doença relacionada.